Anti-Alzheimer's flavanolignans from Ceiba pentandra aerial parts

被引:18
作者
Abouelela, Mohamed E. [1 ]
Orabi, Mohamed A. A. [1 ]
Abdelhamid, Reda A. [1 ]
Abdelkader, Mohamed S. A. [2 ]
Darwish, Faten M. M. [3 ]
Hotsumi, Mayumi [4 ]
Konno, Hiroyuki [4 ]
机构
[1] Al Azhar Univ, Fac Pharm, Dept Pharmacognosy, Assiut Branch, Assiut 71524, Egypt
[2] Sohag Univ, Fac Pharm, Dept Pharmacognosy, Sohag 11432, Egypt
[3] Assiut Univ, Fac Pharm, Dept Pharmacognosy, Assiut 71526, Egypt
[4] Yamagata Univ, Grad Sch Sci & Engn, Dept Biochem Engn, Yonezawa, Yamagata 9928510, Japan
关键词
Ceiba pentandra; Bombacaceae; Flavanolignan; Ceibapentains; Amyloid beta 42; Anti-Alzheimer's; AMYLOID AGGREGATION; CONSTITUENTS; OLIGOMERS; TANNINS;
D O I
10.1016/j.fitote.2020.104541
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Four flavanolignans, ceibapentains A (1) and B (2) and cinchonains Ia (3) and Ib (4), were isolated for the first time from an ethyl acetate extract of Ceiba pentandra (L) (Bombacaceae) aerial parts. The ceibapentains A (1) and B (2) are new compounds and their structures, including the absolute configurations, were determined by HRESIMS, 1D and 2D NMR, and electronic circular dichroism analyses, then compared with reported data. Compounds 1-4 were tested for their anti-Alzheimer's activity via an assessment of their inhibitory effect on amyloid beta 42 aggregation using a thioflavin T assay. The results revealed that cinchonain Ia (3) showed a higher inhibitory effect (91%) than the standard curcumin (70%). Compounds 1, 2, and 4 exhibited moderate activity, with inhibition ratios of 43%, 47%, and 58%, respectively. A molecular docking study on the binding mode of 3 and curcumin with an amyloid beta 1-40 peptide fibril structure indicated a high affinity of cinchonain la (3) towards amyloid beta 1-40 peptide, in agreement with the experimental results.
引用
收藏
页数:7
相关论文
共 32 条
[1]   Ethyl acetate extract of Ceiba pentandra (L.) Gaertn. reduces methotrexate-induced renal damage in rats via antioxidant, anti-inflammatory, and antiapoptotic actions [J].
Abouelela, Mohamed E. ;
Orabi, Mohamed A. A. ;
Abdelhamid, Reda A. ;
Abdelkader, Mohamed S. ;
Madkor, Hafez R. ;
Darwish, Faten M. M. ;
Hatano, Tsutomu ;
Elsadek, Bakheet E. M. .
JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE, 2020, 10 (05) :478-486
[2]  
Abouslela M.E., 2019, Saudi Journal of Medical and Pharmaceutical Sciences, V2019, P666
[3]   Flavonoids in the Treatment of Alzheimer's and Other Neurodegenerative Diseases [J].
Airoldi, Cristina ;
La Ferla, Barbara ;
D'Orazio, Giuseppe ;
Ciaramelli, Carlotta ;
Palmioli, Alessandro .
CURRENT MEDICINAL CHEMISTRY, 2018, 25 (27) :3228-3246
[4]   2018 Alzheimer's disease facts and figures [J].
不详 .
ALZHEIMERS & DEMENTIA, 2018, 14 (03) :367-425
[5]  
[Anonymous], HAZZARDS GERIATRIC M
[6]  
[Anonymous], J APPL PHARM SCI
[7]  
[Anonymous], J NEUROCHEM
[8]   Metallostasis in Alzheimer's disease [J].
Ayton, Scott ;
Lei, Peng ;
Bush, Ashley I. .
FREE RADICAL BIOLOGY AND MEDICINE, 2013, 62 :76-89
[9]  
CHEN HF, 1993, PHYTOCHEMISTRY, V33, P183, DOI 10.1016/0031-9422(93)85419-R
[10]   Solution structure of amyloid β-peptide(1-40) in a water-micelle environment.: Is the membrane-spanning domain where we think it is? [J].
Coles, M ;
Bicknell, W ;
Watson, AA ;
Fairlie, DP ;
Craik, DJ .
BIOCHEMISTRY, 1998, 37 (31) :11064-11077